New option available for Alzheimer’s patients as FDA approves expanded drug use
Auvelity is the first FDA-approved non-antipsychotic treatment for Alzheimer's-associated agitation...
Redirecting to full article...
Auvelity is the first FDA-approved non-antipsychotic treatment for Alzheimer's-associated agitation...
Redirecting to full article...